|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
Q4 FY2021
As of Jun 30, 2021
|
Q3 FY2021
As of Mar 31, 2021
|
Q1 FY2021
As of Sep 30, 2020
|
Q4 FY2020
As of Jun 30, 2020
|
Q3 FY2020
As of Mar 31, 2020
|
Q2 FY2020
As of Dec 31, 2019
|
Q1 FY2020
As of Sep 30, 2019
|
Q4 FY2019
As of Jun 30, 2019
|
Q3 FY2019
As of Mar 31, 2019
|
Q2 FY2019
As of Dec 31, 2018
|
Q1 FY2019
As of Sep 30, 2018
|
Q4 FY2018
As of Jun 30, 2018
|
Q3 FY2018
As of Mar 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-Current Assets | ||||||||||||||||||||
| Prepayments/Deposits | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Liabilities and Shareholders' Deficit | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Advanced for share issuance from related party | ||||||||||||||||||||
| Advances from related parties and related party payables | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Shareholders' deficit | ||||||||||||||||||||
| Common stock, $0.0001 par value, 500,000,000 shares authorized, 130,085,501 and 130,085,501 shares issued and outstanding as of March 31, 2023 and June 30, 2022, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total shareholders' deficit | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT | ||||||||||||||||||||
Loading...
